 |
InterPro: IPR010999 Retroviral matrix, N-terminal
Protein matches
|
UniProtKB Matches: 22161 proteins |
|
Accession
|
IPR010999 Retrovr_matrix_N |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Children
|
IPR000840 Gamma-retroviral matrix, N-terminal
IPR003139 Delta-retroviral matrix, N-terminal
IPR003322 Beta-retroviral matrix, N-terminal
IPR012344 Matrix protein, N-terminal, lentiviral and alpha-retroviral
|
GO Term annotation
|
|
Function
|
GO:0005198 structural molecule activity
|
|
Component
|
GO:0019028 viral capsid
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Retroviral matrix proteins (or major core proteins) are components of envelope-associated capsids, which line the inner surface of virus envelopes and are associated with viral membranes [1]. Matrix proteins are produced as part of Gag precursor polyproteins. During viral maturation, the Gag polyprotein is cleaved into major structural proteins by the viral protease, yielding the matrix (MA), capsid (CA), nucleocapsid (NC), and some smaller peptides. Gag-derived proteins govern the entire assembly and release of the virus particles, with matrix proteins playing key roles in Gag stability, capsid assembly, transport and budding. Although matrix proteins from different retroviruses appear to perform similar functions and can have similar structural folds, their primary sequences can be very different. This entry represents structurally homologous matrix proteins from different retroviruses, their structure consisting of four-five alpha helices in a right-handed superhelix. Retroviral matrix proteins bearing this structure have been isolated from Human immunodeficiency virus (HIV), Simian immunodeficiency virus (SIV-cpz), Human T-lymphotropic virus 1, Human T-cell leukemia virus 2 (HTLV-2), Mason-Pfizer monkey virus (MPMV) (Simian Mason-Pfizer virus), Rous sarcoma virus (RSV), Equine infectious anemia virus (EIAV), and Moloney murine leukemia virus (MoMLV). This entry also identifies matrix proteins from several eukaryotic endogenous retroviruses, which arise when one or more copies of the retroviral genome becomes integrated into the host genome [2].
|
Structural links
|
|
Example proteins
|
O12158 Gag-Pol polyprotein
P62683 HERV-K_12q14.1 provirus ancestral Gag polyprotein
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR003308 |
Integrase, N-terminal zinc-binding domain |
 |
| IPR012337 |
Polynucleotidyl transferase, ribonuclease H fold |
 |
| IPR008919 |
Retrovirus capsid, N-terminal core |
 |
| IPR008916 |
Retrovirus capsid, C-terminal |
 |
| IPR002156 |
Ribonuclease H |
 |
| IPR018061 |
Peptidase A2A, retrovirus RVP subgroup |
 |
| IPR001878 |
Zinc finger, CCHC-type |
 |
| IPR017856 |
Integrase, N-terminal zinc-binding domain-like |
 |
| IPR009007 |
Peptidase aspartic, catalytic |
 |
| IPR001969 |
Peptidase aspartic, active site |
 |
| IPR010659 |
Reverse transcriptase connection |
 |
| IPR003322 |
Beta-retroviral matrix, N-terminal |
 |
| IPR010999 |
Retroviral matrix, N-terminal |
 |
| IPR010661 |
Reverse transcriptase thumb |
 |
| IPR000477 |
RNA-directed DNA polymerase (reverse transcriptase) |
 |
| IPR013084 |
Zinc finger, CCHC retroviral-type |
 |
| IPR000721 |
Retroviral nucleocapsid protein Gag |
 |
| IPR000071 |
Immunodeficiency lentiviral matrix, N-terminal |
 |
| IPR012344 |
Matrix protein, N-terminal, lentiviral and alpha-retroviral |
 |
| IPR001584 |
Integrase, catalytic core |
 |
| IPR001995 |
Peptidase A2A, retrovirus, catalytic |
 |
| IPR001037 |
Integrase, C-terminal, retroviral |
 |
|
SWISS-MODEL |
 |
|
PDB Chain |
 |
|
CATH Domain |
 |
|
Additional Reading
|
|
Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP.
Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.
J. Mol. Biol. 373 2007 355-66
[PubMed: 17826792]
http://dx.doi.org/10.1016/j.jmb.2007.07.070
|
|
Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF.
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc. Natl. Acad. Sci. U.S.A. 103 2006 11364-9
[PubMed: 16840558]
http://dx.doi.org/10.1073/pnas.0602818103
|
|
Saad JS, Loeliger E, Luncsford P, Liriano M, Tai J, Kim A, Miller J, Joshi A, Freed EO, Summers MF.
Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
J. Mol. Biol. 366 2007 574-85
[PubMed: 17188710]
http://dx.doi.org/10.1016/j.jmb.2006.11.068
|
|
Kelly BN, Howard BR, Wang H, Robinson H, Sundquist WI, Hill CP.
Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278).
Biochemistry 45 2006 11257-66
[PubMed: 16981686]
http://dx.doi.org/10.1021/bi060927x
|
|
Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF.
Entropic switch regulates myristate exposure in the HIV-1 matrix protein.
Proc. Natl. Acad. Sci. U.S.A. 101 2004 517-22
[PubMed: 14699046]
http://dx.doi.org/10.1073/pnas.0305665101
|
|
|
InterPro 23.1
|